US8523123052
© BusinessWire
11.12.2025
STAA
LISTED
NASDAQ
STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today issued the following statement to correct misinformation regarding its robust go-shop process to evaluate available alternatives to the pending merger with Alcon (SIX/NYSE: ALC).
Broad...
Themefolio
Profiler
Peergroup
© BusinessWire
11.12.2025
STAA
LISTED
NASDAQ
Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon
News Preview
Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood,” “we,” “us” or “our”) today reacted to the proxy statement supplement filed by STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) with respect to the proposed acquisition of the Company by Alcon Inc. (“Alcon”) (NYSE: ALC). In addition, Broadwood released a new pre...
Themefolio
Profiler
Peergroup
© BusinessWire
10.12.2025
STAA
LISTED
NASDAQ
Yunqi Capital Comments on STAAR Surgical’s Go-Shop Process and Alcon’s Revised Offer
News Preview
Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), today released the following letter to STAAR shareholders regarding the closing of STAAR’s go-shop period and the revised offer of Al...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
09.12.2025
STAA
LISTED
NASDAQ
Broadwood Partners Responds to Alcon’s Increase to Proposed Acquisition Price of STAAR Surgical
News Preview
Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood,” “we,” “us” or “our”) today responded to the amended transaction terms of the proposed acquisition of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) by Alcon Inc. (“Alcon”) (NYSE: ALC).
Broadwood, which owns 30.2% of STAAR’s outstanding common stock, continue...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
08.12.2025
STAA
LISTED
NASDAQ
Broadwood Partners Reiterates Opposition to STAAR Surgical’s Sale to Alcon Following Conclusion of Performative Go-Shop Process
News Preview
Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood,” “we,” “us,” or “our”) today issued the following open letter to the shareholders of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA). Broadwood, which owns 30.2% of STAAR’s outstanding common stock, continues to oppose the proposed sale of the Company to Alcon...
Themefolio
Profiler
Peergroup
© BusinessWire
08.12.2025
STAA
LISTED
NASDAQ
Broadwood Partners: Proxy Advisory Firm Egan-Jones Reaffirms Its Recommendation STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon
News Preview
Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today announced that leading proxy advisory firm Egan-Jones Ratings Company (“Egan-Jones”) has reaffirmed its recommendation that shareholders vote “AGAINST” the proposed acquisition of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) by Alcon Inc. (“Alcon”) (N...
Themefolio
Profiler
Peergroup
© BusinessWire
08.12.2025
STAA
LISTED
NASDAQ
STAAR Surgical Announces Expiration of Go-Shop Period
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the expiration of the previously announced go-shop period pursuant to STAAR’s amended merger agreement with Alcon Inc. (SIX/NYSE: ALC). The go-shop period expired at 11:59 p.m...
Themefolio
Profiler
Peergroup
© BusinessWire
02.12.2025
STAA
LISTED
NASDAQ
Broadwood Partners Working to Call Special Meeting of STAAR Surgical Shareholders to Remove Three Directors
News Preview
Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today announced that it is well along in the multi-step and time-consuming process that is required to call a Special Meeting of Shareholders (the “Special Meeting”) at STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) to remove three directors from the Company’...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
STAA
LISTED
NASDAQ
Broadwood Partners Calls for the Appointment of New Directors at STAAR Surgical to Oversee Go-Shop Process
News Preview
Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today commented on the recent filing of amendments to the merger agreement in connection with the proposed sale of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) to Alcon Inc. (“Alcon”) (NYSE: ALC).
Neal C. Bradsher, Founder and President of Broadwood, said...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2025
STAA
LISTED
NASDAQ
STAAR Surgical Announces Amendments to Alcon Merger Agreement
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that the Company has agreed with Alcon Inc. (SIX/NYSE: ALC) to amend their merger agreement to allow proactive solicitation by STAAR of third-party proposals to maximize value...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
STAA
LISTED
NASDAQ
Yunqi Capital Applauds STAAR Surgical’s Strong Third Quarter Results and Reiterates That the Proposed Sale to Alcon Should Be Terminated
News Preview
Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ:STAA), today released the following letter to the Board of Directors of STAAR after reviewing STAAR’s third quarter earnings press release an...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2025
STAA
LISTED
NASDAQ
STAAR Surgical Reports Third Quarter 2025 Results
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the third quarter ended September 26, 2025.
Third Quarter 2025 Financial Overview
Net sales of $94.7 million up 6.9% Y/Y
Net sales included $25.9 million relat...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
04.11.2025
STAA
LISTED
NASDAQ
Broadwood Partners Condemns Alcon’s Fallacious Attacks on STAAR Surgical and Its Prospects
News Preview
Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today commented on the investor presentation issued by Alcon Inc. (“Alcon”) (NYSE: ALC) regarding its proposed acquisition of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA). Broadwood, which owns 27.5% of STAAR’s outstanding common stock, continues to urge its fell...
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2025
STAA
LISTED
NASDAQ
Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon
News Preview
Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ:STAA), today released the following letter to the Board of Directors of STAAR after its decision to postpone STAAR’s Special Meeting of Stock...
Themefolio
Profiler
Peergroup
© BusinessWire
27.10.2025
STAA
LISTED
NASDAQ
STAAR Surgical Sets New Record Date and Postpones STAAR Special Meeting of Stockholders in Light of Ongoing Discussions with Alcon
News Preview
STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL) announced that, in light of ongoing discussions with Alcon (SIX/NYSE: ALC), STAAR’s Special Meeting of Stockholders in connection with STAAR’s merger agreement with Alcon (the “Special Meeting”), which was previously adjourned until November 6, 2025 at...
Themefolio
Profiler
Peergroup
© BusinessWire
25.10.2025
STAA
LISTED
NASDAQ
Yunqi Capital Issues Letter to STAAR Surgical Board Opposing Adjournment of the Special Meeting and Calling for the Company to Move Beyond the Proposed Merger with Alcon
News Preview
Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ:STAA), today released the following letter to the Board of Directors of STAAR after the decision by STAAR Surgical and Alcon Inc. (SIX/NYSE:A...
Themefolio
Profiler
Peergroup
© BusinessWire
24.10.2025
STAA
LISTED
NASDAQ
Broadwood Partners Condemns Decision by STAAR Surgical and Alcon to Delay Final Vote on Proposed Transaction
News Preview
Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”), which owns 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), today issued the following statement regarding the agreement between STAAR and Alcon Inc. (“Alcon”) (NYSE: ALC) to postpone a shareholder vote on the proposed sale...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
STAA
LISTED
NASDAQ
Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL), today announced that STAAR and Alcon have agreed to adjourn STAAR’s Special Meeting of Stockholders (the “Special Meeting”) scheduled for October 23,...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
STAA
LISTED
NASDAQ
Broadwood Partners Intends to Call Special Meeting to Remove Several STAAR Surgical Directors
News Preview
Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”), which owns 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), notified the Company’s Board of Directors (the “Board”) yesterday that it intends to call a Special Meeting of STAAR shareholders for the purpose of removing severa...
Themefolio
Profiler
Peergroup
© BusinessWire
20.10.2025
STAA
LISTED
NASDAQ
Yunqi Capital Issues Letter to STAAR Surgical’s Board Calling for Timely Convening of the Special Meeting to Vote on the Alcon Transaction
News Preview
Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ:STAA), today issued the following letter to the Board of Directors of STAAR regarding Yunqi’s opposition to the proposed sale to Alcon Inc. (...
Themefolio
Profiler
Peergroup
© BusinessWire
20.10.2025
STAA
LISTED
NASDAQ
Broadwood Partners Highlights Growing Opposition to STAAR Surgical’s Proposed Sale to Alcon
News Preview
Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today commented on the increasing public opposition to the proposed acquisition of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) by Alcon Inc. (“Alcon”) (NYSE: ALC). Broadwood continues to urge its fellow shareholders to vote on the GREEN Proxy Card “AGAINST” the...
Themefolio
Profiler
Peergroup
© BusinessWire
20.10.2025
STAA
LISTED
NASDAQ
STAAR Surgical Announces Preliminary Net Sales Results for Third Quarter 2025
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced preliminary net sales results for the third quarter ended September 26, 2025. STAAR is announcing its preliminary net sales results in advance of its quarterly earnings announ...
Themefolio
Profiler
Peergroup
© BusinessWire
17.10.2025
STAA
LISTED
NASDAQ
Broadwood Partners Issues Letter to STAAR Surgical’s Board Urging it to Allow Timely Shareholder Vote on Alcon Sale
News Preview
Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today issued the following letter to the Board of Directors (the “Board”) of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA). Broadwood, which owns 27.5% of STAAR’s outstanding common shares, urges its fellow shareholders to vote on its GREEN Proxy Card “AGAIN...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
STAA
LISTED
NASDAQ
STAAR Surgical Affirms that No Acquisition Proposals Have Been Received From Any Party Other Than Alcon
News Preview
STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today issued the following statement:
Broadwood Partners’ statements and assertions regarding interest in STAAR are misleading and distort the truth. Broadwood is misrepresenting...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
STAA
LISTED
NASDAQ
Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon
News Preview
Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today announced that Institutional Shareholder Services Inc. (“ISS”), a leading independent proxy advisory firm, has recommended that the shareholders of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) vote “AGAINST” the Company’s proposed acquisition by Alcon Inc....
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
STAA
LISTED
NASDAQ
Broadwood Partners Comments on STAAR Surgical’s Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon
News Preview
Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today commented on the recent Current Report on Form 8-K filed by STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) with the U.S. Securities and Exchange Commission (“SEC”) of a “supplement” to the Company’s definitive proxy statement, filed on September 16, 2025, in...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2025
STAA
LISTED
NASDAQ
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale
News Preview
Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today issued the following letter to the Board of Directors (the “Board”) of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA). Broadwood, which owns 27.5% of STAAR’s outstanding common shares, continues to urge its fellow shareholders to vote on its GREEN Proxy...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2025
STAA
LISTED
NASDAQ
STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote “FOR” the Alcon Merger Agreement on WHITE Proxy Card
News Preview
STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today provided the following statement in response to a report issued by Glass, Lewis & Co., LLC (“Glass Lewis”) related to STAAR’s pending merger with Alcon (SIX/NYSE: ALC):...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2025
STAA
LISTED
NASDAQ
Broadwood Partners: Leading Advisory Firm Glass Lewis Urges STAAR Shareholders to Vote “AGAINST” Sale to Alcon
News Preview
Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today announced that Glass, Lewis & Co., LLC (“Glass Lewis”), a leading independent proxy advisory firm, has recommended that the shareholders of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) vote “AGAINST” the proposed acquisition of STAAR by Alcon Inc. (“Alc...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
STAA
LISTED
NASDAQ
Yunqi Capital, One of STAAR Surgical Company’s Largest Shareholders, Reiterates Its Opposition to the Proposed Merger with Alcon
News Preview
Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ:STAA), today released the following open letter reiterating its opposition to the proposed sale to Alcon Inc. (SIX/NYSE:ALC) on the terms ann...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
STAA
LISTED
NASDAQ
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Judgment in Proposed Sale to Alcon
News Preview
Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today issued the following letter to the Board of Directors (the “Board”) of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA). Broadwood, which owns 27.5% of STAAR’s outstanding common shares, continues to urge its fellow shareholders to vote on its GREEN Proxy...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
STAA
LISTED
NASDAQ
STAAR Surgical: Independent Industry Analysts Recognize Merits of Alcon Merger, the Value It Provides, and the Downside Risks Facing STAAR on Standalone Basis
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today highlighted commentary from numerous independent industry analysts who recognize that STAAR’s merger with Alcon (SIX/NYSE: ALC) – and the compelling, certain, premium cash value it prov...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
STAA
LISTED
NASDAQ
STAAR Surgical Addresses Broadwood Partners’ Flawed, Misleading, and Misinformed Claims
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today issued the following statement with respect to the flawed, misleading, and misinformed claims recently made by Broadwood Partners, L.P.:
Broadwood’s recent presentation recycles flawe...
Themefolio
Profiler
Peergroup
© BusinessWire
03.10.2025
STAA
LISTED
NASDAQ
Broadwood Partners Publishes Presentation Detailing Opposition to STAAR Surgical’s Sale to Alcon
News Preview
Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), today announced that it has published a presentation outlining why stockholders should vote on Broadwood’s GREEN Proxy Card “AGAINST” the propos...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
STAA
LISTED
NASDAQ
Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon’s Acquisition of STAAR
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the manufacturer of the Implantable Collamer® Lens (ICL), today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (HSR), in connection with...
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2025
STAA
LISTED
NASDAQ
STAAR Surgical Publishes Presentation Highlighting Compelling, Certain Cash Value Offered by Alcon Merger and Meaningful Downside Risks if Alcon Merger is not Approved
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today published a presentation reviewing the compelling, certain, premium cash value offered by the Company’s pending merger with Alcon (SIX/NYSE: ALC) and the meaningful downside risks for S...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2025
STAA
LISTED
NASDAQ
Broadwood Partners Files Definitive Proxy Statement Soliciting STAAR Surgical Stockholders to Vote “AGAINST” Proposed Acquisition by Alcon
News Preview
Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) today announced that it has filed a definitive proxy statement and GREEN proxy card with the U.S. Securities and Exchange Commission (the “SEC”)...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
STAA
LISTED
NASDAQ
STAAR Surgical Announces Expiration of “Window Shop” Period; No Competing Acquisition Proposals Received
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the expiration of the 45-day “window shop” period under the terms of the previously announced merger agreement with affiliates of Alcon (SIX/NYSE: ALC). The “window shop” peri...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
STAA
LISTED
NASDAQ
Yunqi Capital, 5.1% Holder and One of STAAR Surgical Company’s Largest Shareholders, Announces Intention to Vote Against the Proposed Sale to Alcon
News Preview
Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR”) (NASDAQ:STAA), today announced its opposition to the Company’s proposed sale to Alcon Inc. (SIX/NYSE:ALC) on the terms announced on August 5, 2025.
Yunqi Capital re...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
STAA
LISTED
NASDAQ
STAAR Surgical Board of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it has filed its definitive proxy statement with the U.S. Securities and Exchange Commission in connection with the Company’s pending merger with Alcon (SIX/NYSE: ALC). S...
Themefolio
Profiler
Peergroup
© BusinessWire
15.09.2025
STAA
LISTED
NASDAQ
Shareholder Alert: The Ademi Firm Continues to Investigate Whether STAAR Surgical Company Is Obtaining a Fair Price for Its Public Shareholders
News Preview
The Ademi Firm continues to investigate STAAR (NASDAQ: STAA) for possible breaches of fiduciary duty and other violations of law in its transaction with Alcon Inc.
Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
STAA
LISTED
NASDAQ
STAAR Surgical Reiterates Compelling, Premium Cash Value Provided by Alcon Merger
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, issued the following statement:
“The merger with Alcon provides STAAR stockholders with compelling, premium cash value, including a 51% premium to the closing price of STAAR common stock on...
Themefolio
Profiler
Peergroup
© BusinessWire
01.08.2025
STAA
LISTED
NASDAQ
STAAR Surgical to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it will release financial results for the second quarter ended June 27, 2025, on Wednesday, August 6, 2025 after the market close. The Company will also host an earnings...
Themefolio
Profiler
Peergroup
© BusinessWire
25.06.2025
STAA
LISTED
NASDAQ
STAAR Surgical Announces Appointment of Deborah Andrews as Chief Financial Officer, Forms Capital Stewardship Committee of the Board of Directors
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that Deborah Andrews has been appointed Chief Financial Officer, effective June 25, 2025. Ms. Andrews has served as Interim CFO since March 2025, and she previously served as...
Themefolio
Profiler
Peergroup
© BusinessWire
22.05.2025
STAA
LISTED
NASDAQ
STAAR Surgical Announces Participation in Upcoming Investor Conferences
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that management will participate in the following upcoming conferences:
Stifel 2025 Virtual Ophthalmology Forum
Date: Tuesday, May 27, 2025
Format: Meetings and Webcast Fires...
Themefolio
Profiler
Peergroup
© BusinessWire
16.05.2025
STAA
LISTED
NASDAQ
STAAR Surgical Announces $30 Million Share Repurchase Authorization
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that its Board of Directors has authorized a share repurchase program under which the Company may repurchase up to $30 million of its outstanding common stock.
“Our decision...
Themefolio
Profiler
Peergroup
© BusinessWire
07.05.2025
STAA
LISTED
NASDAQ
STAAR Surgical Reports First Quarter 2025 Results
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the first quarter ended March 28, 2025.
First Quarter 2025 Financial Overview
Net sales of $42.6 million down 45% Y/Y due to planned reduction of channel invento...
Themefolio
Profiler
Peergroup
© BusinessWire
24.04.2025
STAA
LISTED
NASDAQ
STAAR Surgical Announces Changes to Board of Directors
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced changes to its Board of Directors. The Company announced that the Board appointed Louis E. Silverman, who served on the Company’s Board from 2014-2022, as a director, effectiv...
Themefolio
Profiler
Peergroup
© BusinessWire
23.04.2025
STAA
LISTED
NASDAQ
STAAR Surgical to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it will release financial results for the first quarter ended March 28, 2025, on Wednesday, May 7, 2025 after the market close. The Company will also host an earnings cal...
Themefolio
Profiler
Peergroup
© BusinessWire
17.03.2025
STAA
LISTED
NASDAQ
STAAR Surgical Announces Realignment of Leadership Structure
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the following changes to right size and realign its leadership structure to better address market needs:
Warren Foust, Chief Operating Officer, has been promoted to the newl...
Themefolio
Profiler
Peergroup
© BusinessWire
26.02.2025
STAA
LISTED
NASDAQ
STAAR Surgical Announces Leadership Transition
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced a leadership transition. Stephen C. Farrell, current Lead Independent Director of the STAAR Board of Directors, has been appointed President and CEO, effective February 26, 20...
Themefolio
Profiler
Peergroup
© BusinessWire
13.02.2025
STAA
LISTED
NASDAQ
STAA Investors Have Opportunity to Join STAAR Surgical Company Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of STAAR Surgical Company (“Staar” or “the Company”) (NASDAQ: STAA) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to...
Themefolio
Profiler
Peergroup
© BusinessWire
11.02.2025
STAA
LISTED
NASDAQ
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2024 Results
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the fourth quarter and fiscal year ended December 27, 2024. The Company moved up its earnings announcement and will hold a conference call and webcast today at 5:00...
Themefolio
Profiler
Peergroup
© BusinessWire
13.01.2025
STAA
LISTED
NASDAQ
STAAR Surgical to Host Fourth Quarter and Fiscal Year 2024 Earnings Conference Call and Webcast on February 19, 2025
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it will release financial results for the fourth quarter and fiscal year ended December 27, 2024, on or about Wednesday, February 19 after the market close.
“Our indust...
Themefolio
Profiler
Peergroup
© BusinessWire
25.11.2024
STAA
LISTED
NASDAQ
STAAR Surgical to Participate in BTIG Ophthalmology Day
News Preview
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that management will participate in meetings with investors and a fireside chat at the 4th Annual BTIG Ophthalmology Day.
Event: 4th Annual BTIG...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2024
STAA
LISTED
NASDAQ
STAAR Surgical to Participate in Stephens Annual Investment Conference (NASH2024)
News Preview
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, invites investors and the general public to listen to a webcast fireside chat with STAAR Management at the upcoming Stephens Annual Investment Conference, which w...
Themefolio
Profiler
Peergroup
© PR Newswire
04.11.2024
STAA
LISTED
NASDAQ
STAAR Surgical™ and Lucy Bronze, MBE, See Eye to Eye on Vision Correction
News Preview
Women's football star benefits on and off the pitch from EVO ICL™ vision correction procedure
LONDON, Nov. 4, 2024 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer, and marketer of the EVO family of Implantable Collamer® lenses (EVO ICL™) for myopia, astigmatism and presbyopia, is proud to announce a co...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2024
STAA
LISTED
NASDAQ
STAAR Surgical Reports Third Quarter 2024 Results
News Preview
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today reported financial results for the third quarter ended September 27, 2024.
This press release features multimedia. View the full release here: https://www.b...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2024
STAA
LISTED
NASDAQ
CORRECTING and REPLACING STAAR Surgical Reports Third Quarter 2024 Results
News Preview
The end of the paragraph after bullets in the "Outlook" section of release should read: APAC sales growth of 5% (prior outlook was 7%), including approximately 2% growth in China (prior outlook was 10%) and all other APAC countries approximately 10-20% growth (prior outlook was flat). (Instead of: APAC sales growth of 4% (prior outlook was 7%), in...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2024
STAA
LISTED
NASDAQ
STAAR Surgical to Report Third Quarter Results on October 30, 2024
News Preview
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that it will release financial results for the third quarter ended September 27, 2024, on Wednesday, October 30, 2024, after the market close.
Ev...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
